BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34263362)

  • 21. Impact of faecal haemoglobin based triage of bowel symptoms presenting to primary care on colorectal cancer diagnosis.
    Delson D; Ward M; Haddock R; Nobes J; Digby J; Strachan JA; Mowat C
    Colorectal Dis; 2023 Apr; 25(4):787-793. PubMed ID: 36495081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
    Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
    Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
    D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
    Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of 13,466 Fecal Immunochemical Tests in Patients Attending Primary Care for High- and Low-Risk Gastrointestinal Symptoms of Colorectal Cancer.
    Cama R; Kapoor N; Sawyer P; Patel B; Landy J
    Dig Dis Sci; 2023 May; 68(5):2023-2029. PubMed ID: 36357596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
    Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
    United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
    Pin-Vieito N; Iglesias MJ; Remedios D; Rodríguez-Alonso L; Rodriguez-Moranta F; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Martínez-Bauer E; Campo R; Bujanda L; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Cubiella J; On Behalf Of The Colonpredict Study Investigators
    World J Gastroenterol; 2020 Jan; 26(1):70-85. PubMed ID: 31933515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients.
    D'Souza N; Monahan K; Benton SC; Wilde L; Abulafi M;
    Colorectal Dis; 2021 Oct; 23(10):2539-2549. PubMed ID: 34240526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot.
    Saw KS; Sexton K; Frankish P; Hulme-Moir M; Bissett I; Parry S
    BMJ Open Gastroenterol; 2023 Nov; 10(1):. PubMed ID: 38007223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaemia as a risk stratification tool for symptomatic patients referred via the two-week wait pathway for colorectal cancer.
    Mashlab S; Large P; Laing W; Ng O; D'Auria M; Thurston D; Thomson S; Acheson AG; Humes DJ; Banerjea A;
    Ann R Coll Surg Engl; 2018 May; 100(5):350-356. PubMed ID: 29543046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
    Tourne-Garcia C; Perez-Riquelme F; Monteagudo-Piqueras O; Fraser CG; Yepes-Garcia P
    J Med Screen; 2022 Dec; 29(4):231-240. PubMed ID: 35578555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating faecal haemoglobin measurement using the faecal immunochemical test (FIT) in the referral, triage and prioritisation pathway for patients with colorectal symptoms.
    Falvey J; Frampton CMA; Gearry RB; Hudson B; Whiteley L
    N Z Med J; 2023 Jul; 136(1578):55-76. PubMed ID: 37414077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population.
    MacDonald S; MacDonald L; Godwin J; Macdonald A; Thornton M
    Colorectal Dis; 2022 Mar; 24(3):257-263. PubMed ID: 34797583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems.
    Benton SC; Piggott C; Zahoor Z; O'Driscoll S; Fraser CG; D'Souza N; Chen M; Georgiou Delisle T; Abulafi M
    Clin Chem Lab Med; 2022 Jul; 60(8):1278-1286. PubMed ID: 35637625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia.
    Ayling RM; Lewis SJ; Cotter F
    Br J Haematol; 2019 Apr; 185(2):311-316. PubMed ID: 30714125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of the faecal immunochemical test on colorectal cancer survival.
    Gutierrez-Stampa MA; Aguilar V; Sarasqueta C; Cubiella J; Portillo I; Bujanda L
    BMC Cancer; 2020 Jul; 20(1):616. PubMed ID: 32611328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.